Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1975 Apr;20(1):161–177.

Ultrastructural and serological studies on the resistance of activated B cells to the cytotoxic effects of anti-immunoglobulin serum. Patch and cap formation of surface immunoglobulin on mitotic B lymphocytes.

R S Kerbel, M S Birbeck, D Robertson, P Cartwright
PMCID: PMC1538184  PMID: 1106920

Abstract

Previous studies have shown that rabbit anti-mouse immunoglobulin sera (anti-Ig) which kill non-activated B lymphocytes in the presence of complement, are incapable of doing so when the cells are activated by antigen or mitogen into mitosis. Results reported here indicate that the resistance is not dependent on either the source of antiserum or complement, or on the presence of a mitotic inhibitor, colcemid. Immunoperoxidase staining-electron microscopy techniques were applied to assess whether there was any conspicuous difference between unstimulated versus mitogen-stimulated, mitotic cells with respect to density or distribution of cell surface Ig. No such differences were found; furthermore, mitotic cells showed rapid classical 'patch and cap' formation of cell surface Ig when incubated with anti-Ig at room temperature, indicating the retention of fluid membrane dynamics by lymphocytes in this stage of the cell cycle. In contrast to this cytotoxic resistance, T or B lymphocytes in mitosis were found to be as sensitive, or more so, to lysis by various other antisera when compared to non-mitotic cells. Thus the resistance of mitotic B cells to the cytotoxic effects of anti-Ig serum seems unique and appears independent of any conspicuous quantitative or qualitative change in cell surface Ig.

Full text

PDF
161

Images in this article

169FIG. 2
on p.169
170FIG. 3
on p.170
171FIG. 4
on p.171
172FIG. 5
on p.172
173FIG. 6
on p.173
174FIG. 7
on p.174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson B., Blomgren H. Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol. 1971 Oct;2(5):411–424. doi: 10.1016/0008-8749(71)90052-9. [DOI] [PubMed] [Google Scholar]
  2. Buell D. N., Fahey J. L. Limited periods of gene expression in immunoglobulin-synthesizing cells. Science. 1969 Jun 27;164(3887):1524–1525. doi: 10.1126/science.164.3887.1524. [DOI] [PubMed] [Google Scholar]
  3. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  4. Cikes M., Friberg S., Jr Expression of H-2 and Moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line. Proc Natl Acad Sci U S A. 1971 Mar;68(3):566–569. doi: 10.1073/pnas.68.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis W. C., Alspaugh M. A., Stimpfling J. H., Walford R. L. Cellular surface distribution of transplantation antigens: discrepancy between direct and indirect labeling techniques. Tissue Antigens. 1971;1(2):89–93. doi: 10.1111/j.1399-0039.1971.tb00083.x. [DOI] [PubMed] [Google Scholar]
  6. Doenhoff M. J., Davies A. J., Leuchars E., Wallis V. The thymus and circulating lymphocytes of mice. Proc R Soc Lond B Biol Sci. 1970 Oct 13;176(1042):69–85. doi: 10.1098/rspb.1970.0035. [DOI] [PubMed] [Google Scholar]
  7. Doenhoff M. J., Janossy G., Greaves M. F., Gomer K. J., Snajdr J. Lymphocyte activation. VI. A re-evaluation of factors affecting the selectivity of polyclonal mitogens for mouse T and B cells. Clin Exp Immunol. 1974 Jul;17(3):475–490. [PMC free article] [PubMed] [Google Scholar]
  8. Dresser D. W., Wortis D. H. Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency. Nature. 1965 Nov 27;208(5013):859–861. doi: 10.1038/208859a0. [DOI] [PubMed] [Google Scholar]
  9. Edelman G. M., Yahara I., Wang J. L. Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci U S A. 1973 May;70(5):1442–1446. doi: 10.1073/pnas.70.5.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fass L., Herberman R. B. A cytotoxic antiglobulin technique for assay of antibodies to histocompatibility antigens. J Immunol. 1969 Jan;102(1):140–144. [PubMed] [Google Scholar]
  11. Forman J., Möller G. The effector cell in antibody-induced cell mediated immunity. Transplant Rev. 1973;17(0):108–149. doi: 10.1111/j.1600-065x.1973.tb00125.x. [DOI] [PubMed] [Google Scholar]
  12. Gorczynski R. M., Rittenberg M. B. Stimulation of early protein synthesis as an assay of immune reactivity: analysis of the cells responding to mitogens and alloantigens. J Immunol. 1974 Jan;112(1):47–55. [PubMed] [Google Scholar]
  13. Graham J. M., Sumner M. C., Curtis D. H., Pasternak C. A. Sequence of events in plasma membrane assembly during the cell cycle. Nature. 1973 Nov 30;246(5431):291–295. doi: 10.1038/246291a0. [DOI] [PubMed] [Google Scholar]
  14. Greaves M., Janossy G. Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev. 1972;11:87–130. doi: 10.1111/j.1600-065x.1972.tb00047.x. [DOI] [PubMed] [Google Scholar]
  15. Hütteroth T. H., Litwin S. D., Cleve H. Cultured lymphoid cell lines from normal subjects: membrane associated immunoglobulins studied by the mixed antiglobulin reaction. Cell Immunol. 1972 Nov;5(3):446–458. doi: 10.1016/0008-8749(72)90071-8. [DOI] [PubMed] [Google Scholar]
  16. Karnovsky M. J., Unanue E. R. Mapping and migration of lymphocyte surface macromolecules. Fed Proc. 1973 Jan;32(1):55–59. [PubMed] [Google Scholar]
  17. Kerbel R. S., Doenhoff M. J. Resistance of mitotic B lymphocytes to cytotoxic effects of anti-Ig serum. Nature. 1974 Jul 26;250(464):342–344. doi: 10.1038/250342a0. [DOI] [PubMed] [Google Scholar]
  18. Kerbel R. S., Elliott E. V., Wallis V. J. Assessment of mitotic thymus-derived lymphocytes by their sensitivity to the cytotoxic effects of anti-theta serum. Cell Immunol. 1974 Mar 30;11(1-3):146–161. doi: 10.1016/0008-8749(74)90015-x. [DOI] [PubMed] [Google Scholar]
  19. Killander D., Klein E., Levin A. Expression of membrane-bound IgM and HL-A antigens on lymphoblastoid cells in different stages of the cell cycle. Eur J Immunol. 1974 May;4(5):327–332. doi: 10.1002/eji.1830040503. [DOI] [PubMed] [Google Scholar]
  20. Leduc E. H., Avrameas S., Bouteille M. Ultrastructural localization of antibody in differentiating plasma cells. J Exp Med. 1968 Jan 1;127(1):109–118. doi: 10.1084/jem.127.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leneva N. V., Svet-Moldavsky G. J. Susceptibility of tumor cells in different phases of the mitotic cycle to the effect of immune lymphocytes. J Natl Cancer Inst. 1974 Mar;52(3):699–704. doi: 10.1093/jnci/52.3.699. [DOI] [PubMed] [Google Scholar]
  22. Lerner R. A., Oldstone M. B., Cooper N. R. Cell cycle-dependent immune lysis of Moloney virus-transformed lymphocytes: presence of viral antigen, accessibility to antibody, and complement activation. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2584–2588. doi: 10.1073/pnas.68.10.2584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Levey R. H., Medawar P. B. Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1130–1137. doi: 10.1073/pnas.56.4.1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Möller G. 19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature. 1965 Sep 11;207(5002):1166–1168. doi: 10.1038/2071166a0. [DOI] [PubMed] [Google Scholar]
  25. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  26. Pross H., Novak T., Eidinger D. In vitro studies of "antigenic competition". I. The comparative responses of normal and "immune" lymphoid cell populations. Cell Immunol. 1971 Oct;2(5):445–457. doi: 10.1016/0008-8749(71)90055-4. [DOI] [PubMed] [Google Scholar]
  27. Rabinowitz S. G., Adler W. H. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells. J Immunol. 1973 May;110(5):1345–1353. [PubMed] [Google Scholar]
  28. Raff M. C., De Petris S. Movement of lymphocyte surface antigens and receptors: the fluid nature of the lymphocyte plasma membrane and its immunological significance. Fed Proc. 1973 Jan;32(1):48–54. [PubMed] [Google Scholar]
  29. Rubio N. Surface H-2 antigen concentration requirement of somatic hybrid cells for IgM-mediated cytotoxicity. Nature. 1974 May 31;249(456):461–463. doi: 10.1038/249461a0. [DOI] [PubMed] [Google Scholar]
  30. Shipley W. U. Immune cytolysis in relation to the growth cycle of Chinese hamster cells. Cancer Res. 1971 Jul;31(7):925–929. [PubMed] [Google Scholar]
  31. Shohat M., Janossy G., Dourmashkin R. R. Development of rough endoplasmic reticulum in mouse splenic lymphocytes stimulated by mitogens. Eur J Immunol. 1973 Nov;3(11):680–687. doi: 10.1002/eji.1830031106. [DOI] [PubMed] [Google Scholar]
  32. Takahashi M., Yagi Y., Moore G. E., Pressman D. Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol. 1969 Oct;103(4):834–843. [PubMed] [Google Scholar]
  33. Takahashi T., Mond J. J., Carswell E. A., Thorbecke G. J. The importance of theta and Ig hearing cells in the immune response to various antigens. J Immunol. 1971 Dec;107(6):1520–1526. [PubMed] [Google Scholar]
  34. Takahashi T., Old L. J., McIntire K. R., Boyse E. A. Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med. 1971 Oct 1;134(4):815–832. doi: 10.1084/jem.134.4.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. de Petris S., Raff M. C. Normal distribution, patching and capping of lymphocyte surface immunoglobulin studied by electron microscopy. Nat New Biol. 1973 Feb 28;241(113):257–259. doi: 10.1038/newbio241257a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES